FDA Quickly Authorizes Its 2nd Blood Filtering Device for COVID-19
04/14/2020
Shortly after granting an emergency authorization to Terumo BCT’s blood filtering device for COVID-19, the FDA did the same for CytoSorbents’ system, according to a FierceBiotech report. Both are designed to strip out the immune system proteins that fuel the deadly cytokine-storm reactions associated with the disease.
Previously cleared for use in the European Union, the company’s CytoSorb purification system has been used to treat septic shock patients receiving intensive care, as well as those undergoing heart surgery or experiencing liver failure. Now with the FDA’s blessing, the filters can be used in U.S. intensive care units for adults suffering from imminent respiratory failure, with acute lung injuries or severe COVID-19 disease.